FDA approves Topicort Topical Spray

FDA approves Topicort Topical Spray

Steve’s breakdown: They say the annual market for this drug is $100 million which translates to a decent size ad account. Check it out.

HAWTHORNE, NY: Taro Pharmaceutical Industries Ltd. reported last week that it has received approval from the U.S. Food and Drug Administration for its New Drug Application Topicort (desoximetasone) Topical Spray, 0.25%.

Topicort Topical Spray, 0.25% is a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years of age or older.

According to industry sources, the corticosteroid spray market is approximately $100 million in annual sales in the U.S.

Taro Pharmaceutical Industries is a multinational, science-based pharmaceutical company. For further information on Taro, visit its website at Taro.com.


Type and press Enter to search